(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)
Click on image to view larger version.

Fig. 4. Distinct pharmacological properties of EPPs recorded from wild-type
and
-/- muscles. (A) Sample EPP traces
recorded from wild-type or
-/- muscles in normal Ringer's,
or in Ringer's with
A-conotoxin OIVB (10 µM). (B)
Quantification of normalized EPP amplitudes. EPPs in wild-type muscles, but
not
-/- muscles, were sensitive to
A-conotoxin OIVB.
(C) Sample EPP traces recorded from wild-type or
-/-
muscles in normal Ringer's, or in Ringer's with waglerin 1 (1 µM).
(D) Quantification of normalized EPP amplitudes. Bath application of
waglerin 1 (1 µM) in Ringer's completely blocked the EPPs in the
-/- muscles, but was much less effective in the wild-type
muscles. *P<0.05, ***P<0.001
(Student's t-test).